Wedbush Securities Believes SH Data Bodes Well For Pacira Pharmaceuticals
March 25, 2015 at 10:14 AM EDT
In a report published Wednesday, Wedbush Securities analyst Liana Moussatos reiterated an Outperform rating and $127.00 price target on ...